Newsletter Edition #175 [Treaty Talks]
Dear Readers,
Those of you who are regular readers of the Files know that we have been following discussions on WHO’s Pathogen Access Benefit Sharing system for the last three years.
These negotiations are also unfolding at a time when the World Health Organization is electing its new leader in May 2027.
It is inevitable that the razzmattaz around the elections at the WHO, would rub off on the technical yet political negotiations that continues to have countries engaged.
For most of this month, I spent significant amount of time at the WHO tracking the closed-door negotiations on Pathogen Access Benefit Sharing system. Sometimes, the conversations on the elections in the corridors, occurred alongside casual deliberations on the legal text under negotiation by countries.
Negotiators are fully focused on bridging positions, and framing obligations on these issues. But the political nature of these things mean, that it may not always be possible to keep simultaneous developments watertight.
There are two parts to this edition: a wrap on the negotiations themselves; second, the PABS talks from the lens of the elections.
Reporting and writing this story was far from straightforward. We weighed our words carefully, respecting the sensitivity of diplomatic spaces while acting in the public interest without causing externalities to the negotiations themselves.
Just to re-emphasize, we do not take sides. This reader-funded publication is always on the side of public interest - everywhere. Loosely attributing motives to us just because we are raising questions is not helpful.
Thank you for reading. Support us?
Geneva Health Files offers value to our readers who are experts in global health. Tracking global health policy-making in Geneva is tough and expensive, without institutional support. For six years, we have provided you with the information and tools that directly contribute to your work in the field. We rely on our readers who value news they can use.
By becoming a paying subscriber you make our work possible and help us gather, report and synthesise global health intelligence.
Best,
Priti
Priti Patnaik, Founder & Publisher, Geneva Health Files
Feel free to write to us: genevahealthfiles@gmail.com ; Find us on BlueSky, Instagram and Linkedin.
Presenting our weekly in-depth analysis on global health that captures the big picture and the nuances like no one else does. This is an exclusive edition for our subscribers.

I. IGWG9 UPDATE
PART I
Global Health Negotiations Proceed in the Backdrop of Elections at the WHO
By Priti Patnaik
Technical negotiations are moulded by political forces. In global health, we appear to be at an important intersection of interests.
The negotiations on the Pathogen Access Benefits Sharing System at the WHO, resumed this month, close on the heels of the Lula victory in Brazil. The importance of the electoral outcome on these negotiations is not insignificant: for one, Brazilian Co-Chair of the Intergovernmental Working Group, Ambassador Tovar da Silva Nunes is expected to continue shepherding these talks. Overall, Brazil’s leadership in these negotiations, and in the overall multilateral sphere became more significant in the context of the general direction of politics in Latin America. (Tovar is now also joined by French Ambassador Anne-Claire Amprou, whose election as a co-chair is a credible sign of the EU’s commitment to these talks.)
No sooner than the talks began, news across the Atlantic was definitive. American voters ushered in a fundamental political shift in the U.S. midterm elections that brought the democrats back from the red. At the WHO, it seems to have generated cautious optimism on what it could mean for American engagement with the institution in the medium term.
As if such a colored political context was not already enough, closer home in Geneva, the negotiations went apace with election processes for the appointment of the next Director General - now decisively underway.
In this story, we briefly recap some of the issues that came up for deliberations during November 2-13. We spoke with numerous delegations and experts throughout this period.